HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)

The role of phosphatidylcholine and choline metabolites to cell proliferation and survival

(2013) Neale D. Ridgway   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer

(2013) J.M. Mates et al.   CURRENT MOLECULAR MEDICINE

Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer

(2013) Meghan L Verschoor et al.   Molecular Cancer

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

(2013) Hui Shen et al.   Nature Communications

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer

(2013) Panagiotis A. Konstantinopoulos et al.   Frontiers in Oncology

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Metabolic cues from the microenvironment act as a major selective factor for cancer progression and metastases formation

(2011) Jacinta Serpa et al.   CELL CYCLE

Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells?

(2010) Chi V. Dang   CELL CYCLE

DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells

(2009) Florian T Unger et al.   BMC CANCER

RLIP76: A novel glutathione-conjugate and multi-drug transporter

(2008) Sharad S. Singhal et al.   BIOCHEMICAL PHARMACOLOGY

Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase

(2008) Christopher C. Franklin et al.   MOLECULAR ASPECTS OF MEDICINE